Suchergebnisse - "Infusion related reaction"

PubPharm (125)

1

ENSEMBLE PLUS : final results of shorter ocrelizumab infusion from a randomized controlled trial

enthalten in: Journal of neurology | 2024

von Hartung, H. | Berger, T. | Bermel, R. | +16

2

A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma

enthalten in: Japanese journal of clinical oncology | 2024

von Saito, T. | Nagai, H. | Izutsu, K. | +7

3

Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration : A Retrospective Observational Study

enthalten in: Clinics and practice | 2024

von Hata, K. | Nakamura, K. | Maeda, S. | +3

4

Patients with infusion-related reactions on fixed-dose rituximab treatment have higher body surface area than those without infusion-related reactions in adults with frequently relapsing minimal change nephrotic syndrome : a retrospective study

enthalten in: Journal of pharmaceutical health care and sciences | 2024

von Nishiura, H. | Takahashi, M. | Mori, K. | +3

5

Evaluation of cost and infusion-related reactions among intravenous trastuzumab, subcutaneous trastuzumab, and trastuzumab biosimilars at an academic medical center

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Davis, D. | Jackson, K. | Hoppe, C.

6

The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience

enthalten in: Leukemia & lymphoma | 2024

von Olszewska-Szopa, M. | Ożańska, A. | Ożański, T. | +2

7

Patients with infusion-related reactions on fixed-dose rituximab treatment have higher body surface area than those without infusion-related reactions in adults with frequently relapsing minimal change nephrotic syndrome: a retrospective study

in: Journal of Pharmaceutical Health Care and Sciences | 2024

von Hironobu Nishiura | Masaya Takahashi | Katsuhito Mori | +3

8

Infusion-Related Reactions Induced by Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) : Seven Case Reports

enthalten in: Case reports in oncology | 2024

von Liang, W. | Guo, Z. | Zhang, Y. | +5

9

The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapy

enthalten in: Cancer | 2023

von Tsang, C. | Robinson, J. | Wheatley-Price, P. | +2

10

Characteristics and predictors of infusion-related reactions to rituximab in patients with B-cell non-Hodgkin lymphoma

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Faqeer, N. | Alrabie, R. | Al-Haddadin, R. | +1

ErratumIn: J Chemother. 2024 May;36(3):264-265. - PMID 38616651

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]